C4 Therapeutics, Inc. Profile Avatar - Palmy Investing

C4 Therapeutics, Inc.

C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidate is CFT7…

Biotechnology
US, Watertown [HQ]
Growth Rates · Payout · Yield

Dividends Over Time

  • Records
  • Forecasts [Soon]
Growth Rates
% YoY
% 3Yr
% 5Yr
% 10Yr
Key Metrics
- -% TTM Yield
- - Average Days Gap
Series
% - - Yield
0.00% Payout Ratio
Cash Amount Pay Date
Cash Amount Pay Date
End of CCCC's Analysis
CIK: 1662579 CUSIP: 12529R107 ISIN: US12529R1077 LEI: - UEI: -
Secondary Listings
CCCC has no secondary listings inside our databases.